Neurocrine Biosciences Inc at Jefferies Virtual London Healthcare Conference Transcript
Welcome, everyone, to the Jefferies London Virtual Healthcare Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to introduce our next company. We have Neurocrine Biosciences, Kevin Gorman, their CEO; Matt Abernethy, CFO. And I guess Matt raided my closet and found a similar shirt this morning. So thanks for coordinating on this, Matt.
Yes. No problem. I forgot my glasses at home, but we -- you at least have hair, and I don't. So that's one thing I'll never have again. So thanks for hosting us, and wish we were in London. It's such a beautiful time of the year. But Kevin and I are looking forward to spending time with you today.
Questions & Answers
Great. So let's just talk big picture. I think most investors can say that so far the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |